An August 2009 internal e-mail from DePuy Orthopaedics, Inc.'s vice president confirms that Johnson & Johnson and its subsidiary (DePuy Orthopaedics, Inc.) were well aware of the FDA's refusal to approve the metal-on-metal ASR hip replacement and resurfacing systems a year prior to issuing the now-famous recall. In August of 2010, Johnson & Johnson and DePuy recalled both the ASR XL Acetabular System and the ASR Hip Resurfacing System, after data revealed that both DePuy ASR hip replacement products have excessively high failure rates. Both companies now face thousands of lawsuits from patients that received these implants. Recently, thousands of documents were produced and released under seal in the multidistrict litigation (MDL), one of which is an e-mail from DePuy Orthopaedics vice president, Pamela Plouhar.
Posts tagged "DePuy Orthopaedics"
Since August of 2010, DePuy Orthopaedics, Inc. issued a worldwide recall of both its ASR XL Acetabular System (total hip replacement) and its DePuy ASR Hip Resurfacing System. In 2003, DePuy released the ASR systems and marketed them as a unique, state of the art implants. What made the ASR systems so unique was the metal-on-metal design, and DePuy marketed these implants as a design breakthrough that would revolutionize the industry, last longer, and provide better movement and flexibility to the patients needing a hip replacement.